Clinical Trial Detail

NCT ID NCT03050814
Title Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic Colorectal Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements no
Sponsors National Cancer Institute (NCI)

colorectal cancer


Fluorouracil + Bevacizumab + Capecitabine + Leucovorin + Oxaliplatin

Ad-CEA + Bevacizumab + FOLFOX

Age Groups: adult senior

No variant requirements are available.